PRLog - March 27, 2012 - NEEDHAM, Mass. -- Needham, MA – Cambridge Healthtech Institute announces the keynote presentations for the first annual Bio-IT World Asia Conference, taking place June 6-8, 2012 at the Marina Bay Sands in Singapore.
The Bio-IT World Asia 2012 Conference will bring together, life sciences, pharmaceutical, informatics and IT professionals from all over Asia and the rest of the world to one unique location. The Event provides the perfect venue to share information and discuss enabling technologies that are driving biomedical research and the drug development process.
This year's event’s keynote presentations include:
The HIV/AIDS Pandemic and Prospects for Control
David D. Ho, M.D., Scientific Director & CEO, Aaron Diamond AIDS Research Center
Bio-IT Trends from the Trenches
Chris Dagdigian, Founding Partner and Director, Technology, BioTeam, Inc.
Integrated Bioinformatics Solutions in Drug Discovery & Development
Yaron Turpaz, Ph.D., Vice President, Informatics & Information Sciences, Research & Development Information, AstraZeneca Plc
System Analysis of Complex Bacterial Communities
Peter Little, Ph.D., Professor, Associate Director, Singapore Centre on Life Sciences Engineering;
For more information, visit: http://www.Bio-
About Bio-IT World Events (http://www.Bio-
Since its debut in 2002, the annual Bio-IT World Conference & Expo, held each Spring in Boston, has established itself as a premier event showcasing the myriad applications of IT and informatics to biomedical research and the drug discovery enterprise. Over 2,000 delegates representing 30 countries have gathered yearly to attend 125+ technology and scientific presentations and view an expansive exhibit hall of 100+ companies. Bio-IT World Conference continues its exceptional series of educational programming with the announcement of the Inaugural Bio-IT World Conference Asia.
# # #
Bio-IT World focuses on the tools and results of predictive biology, drug discovery, informatics, clinical trials, and personalized medicine as well as the strategic decisions made by companies in this area and the impact on the company’s performance.